Patent · US Active

Inhibiting agents for Bruton's tyrosine kinase

US10189829B2 · kind B2 · utility

6Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2018
Grant dateJan 29, 2019
Priority date—
Expiry dateAug 27, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.